Zobrazeno 1 - 10
of 34
pro vyhledávání: '"Ta-Hsu Chou"'
Publikováno v:
European Journal of Biochemistry. 1/16/78, Vol. 82 Issue 2, p535-541. 7p.
Publikováno v:
Scandinavian Journal of Haematology. 32:332-334
Copper, ceruloplasmin and sialyltransferase activity were measured in serum of 25 patients with lymphoreticular malignancies, in an attempt to study the sialyltransferase activity and correlation if any with the activity of the disease and ceruloplas
Autor:
Ta-hsu Chou, Lawrence E. Flaherty, Mark M. Zalupski, Lyle L. Sensenbrenner, Joseph P. Uberti, Bruce G. Redman, Maria Dan
Publikováno v:
Journal of Immunotherapy. 18:115-118
Previous reports of autologous bone marrow transplant (auto-BMT) have demonstrated that myeloablative therapy followed by cyclosporin A (CsA), with and without interferon (IFN), can generate autoreactive cytotoxic T lymphocytes (auto-CTL) with potent
Autor:
Mikio Ueda, Indira Joshi, Lyle L. Sensenbrenner, Maria Dan, Ta-hsu Chou, Lawrence G. Lum, Joseph P. Uberti
Publikováno v:
Transplantation. 56:351-355
In order to obtain T cells for adoptive immunotherapy after autologous bone marrow transplantation (ABMT) for patients with resistant hematological malignancies, a culture system was developed for growing T cells and inducing non-MHC-restricted cytot
Publikováno v:
Blood. 79:261-268
We have found that murine lymphokine activated killer (LAK) cells have veto and natural suppressor activities in vitro, and prevent graft- versus-host disease (GVHD) in vivo. To determine whether human LAK cells mediate veto and natural suppression w
Autor:
L. Flaherty, J Kaplan, Ta-Hsu Chou, Bruce G. Redman, Silvana Martino, Michael J. Kraut, Ayad Al-Katib, B Chen, Manuel Valdivieso
Publikováno v:
Journal of Clinical Oncology. 8:1269-1276
Twenty-six patients with metastatic cancer were entered into a phase I trial of concurrent recombinant interleukin-2 (IL-2) and recombinant interferon-gamma (IFN-gamma). IL-2 was administered as a continuous intravenous infusion for 5 days. IFN-gamma
Autor:
James L. Abbruzzese, Melissa L. Bondy, Peter W.T. Pisters, Douglas B. Evans, Ta Hsu Chou, Robert A. Wolff, Rabia Khan, Donghui Li, Li Jiao, Jean Nicolas Vauthey, Renato Lenzi, Manal M. Hassan
Although cigarette smoking is the most well-established environmental risk factor for pancreatic cancer, the interaction between smoking and other risk factors has not been assessed. We evaluated the independent effects of multiple risk factors for p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b4bbcaf2846788f1bbaeb1fb2f6e652a
https://europepmc.org/articles/PMC2423805/
https://europepmc.org/articles/PMC2423805/
Autor:
Robert A. Wolff, Donghui Li, Manal M. Hassan, Renato Lenzi, Ta Hsu Chou, James L. Abbruzzese, Li Jiao, Douglas B. Evans, Maha Ahmed, Melissa L. Bondy, Peter W.T. Pisters, Yanan Li
Publikováno v:
Cancer epidemiology, biomarkersprevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 14(6)
To test the hypothesis that 5,10-methylenetetrahydrofolate reductase (MTHFR) polymorphisms modify the risk of pancreatic cancer, we conducted a hospital-based, case-control study involving 347 patients with newly diagnosed pancreatic adenocarcinoma a
Publikováno v:
Frontiers in bioscience : a journal and virtual library. 9
Cyclooxygenase-2 (COX-2), an inducible prostaglandin G/H synthase, is overexpressed in pre-neoplastic tissues and several human cancers including colorectal cancer. Evidence linking COX-2 activity to carcinogenesis was derived from epidemiologic stud
Autor:
E. Groves, L. Flaherty, Ta-Hsu Chou, Michael S. Simon, Manuel Valdivieso, Michael J. Kraut, Bruce G. Redman, Silvana Martino
Publikováno v:
Journal of immunotherapy : official journal of the Society for Biological Therapy. 12(1)
Fourteen patients were entered into a phase I dose-escalation trial of macrophage colony-stimulating factor (M-CSF). M-CSF was administered to inpatients by rapid 15 min i.v. infusion every 8 h x 5 days, repeated after a 9-day rest. Dose levels evalu